DNA chip receives KFDA approval

Published: 2004-07-22 06:56:00

Updated: 2004-07-22 06:56:00

BiomedLap and Mygene, local biopharmaceutical firms, said on July 20 that it received from the Korea Food and Drug Administration the approval for HPV (human papilloma virus) DNA chip for the first time in Korea.

The commercialized microarray DNA chip may be used to detect HPV infections by re...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK